Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Nutrien Ltd (NYSE: NTR) closed at $59.0 in the last session, up 0.58% from day before closing price of $58.66. In other words, the price has increased by $0.58 from its previous closing price. On the day, 1.59 million shares were traded. NTR stock price reached its highest trading level at $59.209 during the session, while it also had its lowest trading level at $58.04.
Ratios:
We take a closer look at NTR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.67. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.43.
On October 14, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $67.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTR now has a Market Capitalization of 28735336448 and an Enterprise Value of 42109091840. As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.90, and their Forward P/E ratio for the next fiscal year is 12.90. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.07 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 1.64 whereas that against EBITDA is 8.079.
Stock Price History:
The Beta on a monthly basis for NTR is 0.74, which has changed by 0.22386813 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, NTR has reached a high of $65.08, while it has fallen to a 52-week low of $43.69. The 50-Day Moving Average of the stock is 1.99%, while the 200-Day Moving Average is calculated to be 3.94%.
Shares Statistics:
According to the various share statistics, NTR traded on average about 2.66M shares per day over the past 3-months and 2912000 shares per day over the past 10 days. A total of 484.33M shares are outstanding, with a floating share count of 483.03M. Insiders hold about 0.06% of the company’s shares, while institutions hold 75.20% stake in the company. Shares short for NTR as of 1764288000 were 4808680 with a Short Ratio of 1.80, compared to 1761868800 on 4511571. Therefore, it implies a Short% of Shares Outstanding of 4808680 and a Short% of Float of 1.0.
Dividends & Splits
The forward annual dividend rate for NTR is 2.18, which was 2.175 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.037078075. The stock’s 5-year Average Dividend Yield is 3.31.
Earnings Estimates
Nutrien Ltd (NTR) is presently subject to a detailed evaluation by 16.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.53, with high estimates of $0.85 and low estimates of $0.12.
Analysts are recommending an EPS of between $4.86 and $4.5 for the fiscal current year, implying an average EPS of $4.65. EPS for the following year is $4.57, with 23.0 analysts recommending between $5.85 and $3.65.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $5.28B. It ranges from a high estimate of $5.45B to a low estimate of $5.09B. As of. The current estimate, Nutrien Ltd’s year-ago sales were $4.86BFor the next quarter, 7 analysts are estimating revenue of $5.19B. There is a high estimate of $5.29B for the next quarter, whereas the lowest estimate is $5.07B.
A total of 17 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $27.63B, while the lowest revenue estimate was $25.9B, resulting in an average revenue estimate of $26.45B. In the same quarter a year ago, actual revenue was $25.02BBased on 17 analysts’ estimates, the company’s revenue will be $26.67B in the next fiscal year. The high estimate is $28.46B and the low estimate is $25.68B.
